Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial
Titel:
Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial
Auteur:
Ferguson, Gary T FitzGerald, J Mark Bleecker, Eugene R Laviolette, Michel Bernstein, David LaForce, Craig Mansfield, Lyndon Barker, Peter Wu, Yanping Jison, Maria Goldman, Mitchell